title: [Kv1.3 potassium channel expression changes after CD4(+) and subsets CD28(null)/CD28(+)T cells activation in peripheral blood of patients with acute coronary syndrome].
abstract: OBJECTIVE
  To study the Kv1.3 channel expression changes after CD4(+) and subsets CD28(null)/CD28(+)T cells activation in peripheral blood of patients with acute coronary syndrome (ACS).
  
  
  METHODS
  CD4(+)T cell in 27 ACS patients and CD4(+)CD28(null)/CD4(+)CD28(+)T cells in 12 out of these 27 ACS patients were isolated from peripheral blood with magnetic cell sorting. The whole-cell Kv1.3 currents for three T cells were recorded with patch-clamp technique before and 72 hours after activation by purified anti-human CD3 Interferon gamma, tumor necrosis factor alpha (TNF-alpha), granzyme B mRNA expression were determined by reverse transcription-PCR before and 72 hours after activation by purified anti-human CD3 in the presence or absence of recombinant Margatoxin (rMgTX, 0.1, 1, 10 nmol/L), a specific Kv1.3 channel blocker.
  
  
  RESULTS
  Peak Kv1.3 channel currents of CD4(+), CD4(+)CD28(null), CD4(+)CD28(+)T cells were significantly increased and the mean Kv1.3 channel numbers per cell of these cells were increased by about 90%, 60%, 80% (402 +/- 88 vs. 752 +/- 275, 553 +/- 328 vs. 874 +/- 400, 392 +/- 133 vs. 716 +/- 251, all P < 0.05) after activation compared to baseline values. Baseline CD4(+)CD28(null)T cell numbers were about 40% more than those of CD4(+)CD28(+)T cell (P < 0.05) and were similar after activation (P = 0.102). The mRNA expression of interferon gamma, TNF-alpha and granzyme B were dose-dependently down-regulated by rMgTX.
  
  
  CONCLUSIONS
  Kv1.3 channels of peripheral CD4(+)T cell and CD28(null)/CD28(+)T cells from ACS patients significantly increased after activation and Kv1.3-specific channel blocker rMgTX could effectively abolish this effect suggesting a potential role of Kv1.3 channel blocker on plaque stabilization in ACS patients.
authors: Department of Cardiology, Huazhong University of Science and Technology, Wuhan 430030, China.
authors: Da-ying
authors: DY
authors: Feng
authors: Cun-tai
authors: CT
authors: Zhang
authors: Ye-xin
authors: YX
authors: Ma
authors: Hong-lian
authors: HL
authors: Zhou
authors: Ren-de
authors: RD
authors: Xu
authors: Xin-wei
authors: XW
authors: Yang
authors: Shen
authors: S
authors: Huang
authors: Jin
authors: J
authors: Ma
authors: Xiao-qing
authors: XQ
authors: Quan
mesh_terms: D054058:Acute Coronary Syndrome / Q000097:blood / Q000378:metabolism*; D018106:CD28 Antigens / Q000378:metabolism*; D015496:CD4-Positive T-Lymphocytes / Q000378:metabolism*; D005260:Female; D006801:Humans; D051664:Kv1.3 Potassium Channel / Q000378:metabolism*; D008213:Lymphocyte Activation; D008297:Male; D008875:Middle Aged; D018408:Patch-Clamp Techniques; D016176:T-Lymphocyte Subsets / Q000378:metabolism
chemical_list: D018106:CD28 Antigens; D051664:Kv1.3 Potassium Channel